You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Neil Versel is an editor at GenomeWeb. He covers the life science and healthcare informatics markets.
The health system said that the program is encouraging patient compliance and increasing revenues and savings.
The EHR vendor is re-engineering its architecture to increase interoperability with genetic labs and merge genomic and pathology information at the point of care.
The precision medicine company also is accelerating its push into diabetes, depression, and cardiology after getting its solid-tumor test turnaround down to 9 days.
The multi-omics translational software developer is helping the Crohn's & Colitis Foundation validate its research into biomarkers that can predict complications requiring surgery.
Founded by former Inteliquet CEO Carla Balch, the firm is building on visualization technology to help physicians incorporate MDx testing into their practice.
With EMR upgrades, Penn and Rush now have structured genomic data informing clinical decision support in their precision oncology programs, but much work remains.
The OpenNotes movement is encouraging experimentation as some health systems start making complete genomic reports available to patients the moment the lab signs off.
Italy's Dante Labs is building one of Europe's largest genomic labs and leading an effort to sequence 100,000 whole genomes around the Mediterranean.
The new Qlucore Diagnostics software builds on the recently updated Qlucore Omics Explorer platform, initially to help clinicians diagnose and treat leukemia.
The multi-omics analytics company is assisting drug discovery and precision medicine as the first partner of Mayo's Clinical Data Analytics Platform.
Retraction Watch writes that a cancer researcher has had an eighth paper retracted.
Computational biologist James Taylor has died, according to Johns Hopkins University.
The Centers for Disease Control and Prevention is starting to test people for SARS-CoV-2 antibodies, according to the New York Times.
In PLOS this week: features of tumor-infiltrating immune cells, regulatory effects of SNPs associated with prostate cancer risk, and more.